R D Friberg

549 total citations
10 papers, 443 citations indexed

About

R D Friberg is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Physiology. According to data from OpenAlex, R D Friberg has authored 10 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Epidemiology and 2 papers in Physiology. Recurrent topics in R D Friberg's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Pituitary Gland Disorders and Treatments (8 papers) and Thyroid Disorders and Treatments (4 papers). R D Friberg is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Pituitary Gland Disorders and Treatments (8 papers) and Thyroid Disorders and Treatments (4 papers). R D Friberg collaborates with scholars based in United States and Australia. R D Friberg's co-authors include Ariel L. Barkan, Craig A. Jaffe, William F. Chandler, Pin Ho, Ildiko Halasz, Kenneth J. Dornfeld, Howard M. Sandler, C Y Bowers, Bruce Robinson and Paul B. Watkins and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

R D Friberg

10 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R D Friberg United States 9 395 72 63 61 60 10 443
P. Beck-Peccoz Italy 10 394 1.0× 60 0.8× 91 1.4× 41 0.7× 41 0.7× 17 502
Catherine A. Lissett United Kingdom 13 435 1.1× 34 0.5× 50 0.8× 109 1.8× 94 1.6× 18 524
AJ van der Lely Netherlands 5 319 0.8× 119 1.7× 123 2.0× 119 2.0× 26 0.4× 6 445
James Ahlquist United Kingdom 10 331 0.8× 96 1.3× 16 0.3× 15 0.2× 63 1.1× 21 421
J. S. Bevan United Kingdom 9 300 0.8× 124 1.7× 30 0.5× 8 0.1× 57 0.9× 10 380
J. Z. Dong France 5 308 0.8× 66 0.9× 84 1.3× 47 0.8× 85 1.4× 5 454
Sandra Cohen Canada 7 104 0.3× 48 0.7× 39 0.6× 25 0.4× 38 0.6× 13 252
Judith López‐Fernández Spain 10 169 0.4× 21 0.3× 29 0.5× 71 1.2× 82 1.4× 15 309
Yasuhiro Hosoi Japan 9 275 0.7× 46 0.6× 30 0.5× 27 0.4× 80 1.3× 12 380
R. Eshet Israel 14 416 1.1× 78 1.1× 53 0.8× 101 1.7× 187 3.1× 25 579

Countries citing papers authored by R D Friberg

Since Specialization
Citations

This map shows the geographic impact of R D Friberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R D Friberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R D Friberg more than expected).

Fields of papers citing papers by R D Friberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R D Friberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R D Friberg. The network helps show where R D Friberg may publish in the future.

Co-authorship network of co-authors of R D Friberg

This figure shows the co-authorship network connecting the top 25 collaborators of R D Friberg. A scholar is included among the top collaborators of R D Friberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R D Friberg. R D Friberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Barkan, Ariel L., Ildiko Halasz, Kenneth J. Dornfeld, et al.. (1997). Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly1. The Journal of Clinical Endocrinology & Metabolism. 82(10). 3187–3191. 156 indexed citations
2.
3.
Jaffe, Craig A., D. Kim Turgeon, R D Friberg, Paul B. Watkins, & Ariel L. Barkan. (1995). Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.. The Journal of Clinical Endocrinology & Metabolism. 80(11). 3321–3326. 34 indexed citations
4.
Ho, Pin, Craig A. Jaffe, R D Friberg, William F. Chandler, & Ariel L. Barkan. (1994). Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.. The Journal of Clinical Endocrinology & Metabolism. 78(6). 1403–1410. 41 indexed citations
5.
Ho, Pin, Gad B. Kletter, Nancy J. Hopwood, R D Friberg, & Ariel L. Barkan. (1993). Somatostatin withdrawal alone is an ineffective generator of pulsatile growth hormone release in man. European Journal of Endocrinology. 129(5). 414–418. 7 indexed citations
6.
Jaffe, Craig A., R D Friberg, & Ariel L. Barkan. (1993). Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.. Journal of Clinical Investigation. 92(2). 695–701. 73 indexed citations
7.
Friberg, R D, et al.. (1993). Ontogeny of GH mRNA and GH secretion in male and female rats: regulation by GH-releasing hormone. American Journal of Physiology-Endocrinology and Metabolism. 265(2). E236–E242. 16 indexed citations
8.
Ho, Pin, R D Friberg, & Ariel L. Barkan. (1992). Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.. The Journal of Clinical Endocrinology & Metabolism. 75(3). 812–819. 47 indexed citations
9.
Robinson, Bruce, R D Friberg, C Y Bowers, & Ariel L. Barkan. (1992). Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.. The Journal of Clinical Endocrinology & Metabolism. 75(4). 1121–1124. 38 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Beck-Peccoz Breakdown of academic impact, for papers by Catherine A. Lissett Breakdown of academic impact, for papers by AJ van der Lely Breakdown of academic impact, for papers by James Ahlquist Breakdown of academic impact, for papers by J. S. Bevan Breakdown of academic impact, for papers by J. Z. Dong Breakdown of academic impact, for papers by Sandra Cohen Breakdown of academic impact, for papers by Judith López‐Fernández Breakdown of academic impact, for papers by Yasuhiro Hosoi Breakdown of academic impact, for papers by R. Eshet
Rankless by CCL
2026